 |
Monica Heger tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Monica Heger or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Sequenom Runs More Than 13K T21 Tests in Q2; Plans to Expand Capacity in US and Overseas
August 01, 2012
Sequenom Runs More Than 13K T21 Tests in Q2; Plans to Expand Capacity in US and Overseas
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Sequenom Plans Sample-Prep Automation, Increased Multiplexing to Double MaterniT21 Capacity
May 9, 2012 / Clinical Sequencing News - As MaterniT21 Drives Spike in Diagnostic Revenue, Sequenom Predicts 25K Tests Sold in 2012
March 14, 2012 / Clinical Sequencing News - Sequenom Launches MaterniT21 Down Syndrome Test as LDT, Publishes Clinical Validation Study
October 19, 2011 / Clinical Sequencing News - Sequenom Sees Steady Growth of MaterniT21 Test Despite Competition
June 6, 2012 / Clinical Sequencing News - Verinata Licenses Quake Patent, Setting Stage for IP Tussle with Sequenom
September 7, 2011 / Clinical Sequencing News